Integra Lifesciences Holdings Corp
IART
Market Cap$955.08M
Close$
$25.47
92.2% upside
Current Fair Value
92.2% upsideUndervalued by 92.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $955.08 Million |
|---|---|
| Enterprise Value | $715.98 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.09 |
| Beta | 1.17 |
| Outstanding Shares | 76,463,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -32.45 |
|---|---|
| PEG | -4.84 |
| Price to Sales | 0.63 |
| Price to Book Ratio | 1.1 |
| Enterprise Value to Revenue | 0.44 |
| Enterprise Value to EBIT | -23.44 |
| Enterprise Value to Net Income | -25 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Integra Lifesciences Holdings Corp
CEO: Peter Arduini